In conclusion, the supplementation of the somatotropic axis in a murine model of HGNA normalized aminotransferases, reversed sarcopenia and reduced hepatic triglycerides (mainly GH supplementation) and steatosis (IGF-1 supplementation). The gene discussed is GH1; the disease is steatosis.